Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR4/ NF-κB pathway and protecting the intestinal barrier. (2022). Biomolecules and Biomedicine, 22(6), 872-881. https://doi.org/10.17305/bjbms.2022.7348